Skip to main content

Quasi-dendritic sulfonate-based organic small molecule for high-quality NIR-II bone-targeted imaging

Abstract

The visualization of bone imaging in vivo is of great significance for the understanding of some bone-related diseases or physiological processes. Herein, a bone-targeted NIR-II small molecule (TTQF-SO3), which was modified with multiple sulfonate groups, was successfully fabricated for the second near-infrared (NIR-II) bone imaging. In vitro studies revealed that TTQF-SO3 showed high affinity for hydroxyapatite and excellent macrophage accumulation ability. In in vivo assays, TTQF-SO3 displayed high bone uptake ability and high NIR-II bone imaging quality, demonstrating the specific bone-targeting ability of the sulfonate-containing probe. In addition, the noninvasive NIR-II imaging detection in bone calcium loss was successfully verified in osteoporosis mice models. Moreover, the negative charge characteristic of TTQF-SO3 showed efficient lymphoid enrichment in living mice by intravenous injection. Overall, these warrant that our TTQF-SO3 is an optimal bone-targeted diagnostic agent for high-quality NIR-II imaging, highlighting its potential promise for clinical translation.

Graphical Abstract

Introduction

Bone, as a dynamic tissue, is modeled and remodeled by a balance between osteoblast-induced mineralization and osteoclast-induced demineralization [1, 2]. The disruption of this balance is closely related to some diseases, such as osteoporosis, osteoarticular degeneration, and so on [3, 4]. Therefore, real-time visualization of in vivo bone imaging is of great significance for understanding some bone related diseases. However, clinical imaging of bone tissue is entirely based on X-ray or radiochemical methods, which is extremely limited. [5,6,7] By contrast, optical imaging has shown great potential for bone-imaging applications owing to its attractive properties such as nonhazardous, fast feedback, real-time imaging, and low cost [8,9,10,11]. Among them, fluorescence imaging (FI), especially the implementation of FI in the second near-infrared (NIR-II, 1000–1700 nm) region, is undoubtedly advantageous and promising in view of the deep tissue penetration, low autofluorescence, weak photon absorption/scattering, and high image resolution/sensitivity [12,13,14,15]. Therefore, developing bone-targeted NIR-II small-molecule-based fluorophores is highly desirable.

A common feature of most bone targeting agents is the strong affinity for Ca2+ salts. Taking bisphosphonates as the typical bone targeting groups, various bisphosphonate-based fluorescent probes have been extensively applied to bone imaging [16,17,18]. For example, several bisphosphonate-based cyanine derivatives have been reported for bone imaging [19,20,21,22]. Unfortunately, these molecules are limited to NIR-I (700–900 nm) region, which suffers from some shortcomings including poor tissue penetration, low resolution, and high background noise. Moreover, several reports have suggested that bisphosphonate-based fluorescent probes can induce osteoclast apoptosis, which may disrupt the physiological process that should be imaging [23]. More recently, Chen et al. were the first to demonstrate a bone-targeting NIR-II fluorescence probe using azide as bone-enriched group for the high-resolution osteoporosis imaging, but the highly reactive azide groups in the probe may have unknown potential toxicity [24]. Therefore, developing new NIR-II bone-targeting probes with high specificity, in vivo tolerance, excellent biocompatibility and the ability to monitor biological processes over extended periods of time is highly sought after.

Herein, we describe a new structural class of bone-targeting molecular probe with quasi-dendritic molecular structure, named TTQF-SO3. Specifically, the central scaffold of TTQF-SO3 is a donor–acceptor–donor (D–A–D)-based NIR-II fluorophore (TTQF). Through the synthetic chemistry method procedures specific numbers of peripheral sulfonate groups were attached to the central core (Additional file 1: Scheme S1). After systematic studies, including basic photophysical properties, calcium salt affinity, cell imaging, and in vitro imaging, TTQF-SO3 exhibits remarkable bone-seeking property, which is appropriate for further in vivo bone-targeted imaging. Under 808 nm laser radiation, the NIR-II fluorescence imaging (FI) of TTQF-SO3 can clearly observe the skeletal systems of healthy mice. In addition, the noninvasive NIR-II imaging detection in bone calcium loss was successfully verified in osteoporosis mice models. Notably, TTQF-SO3 can provide real-time and long-term observation of the entire skeletal system. Moreover, the negative charge characteristic of TTQF-SO3 showed efficient lymphoid enrichment in living mice by intravenous injection. Overall, TTQF-SO3 is an optimal bone-targeted diagnostic agent for high-quality NIR-II imaging with potential promise for clinical translation.

Results and discussion

The chemical structure of TTQF-SO3 is shown in Fig. 1a, and its detailed synthetic route is displayed in Additional file 1: Scheme S1. First, the D–A–D-based NIR-II dye TTQF-NH2 with functional amino groups was achieved from our previously reported method. Subsequently, TTQF-SO3 was obtained after sulfonation of the intermediate TTQF-NH2 with excess 1,3-propanesultone. The target TTQF-SO3 compound was thoroughly characterized by NMR spectroscopy and MALDI-TOF–MS analysis (Additional file 1: Figs. S1, S2). The eight terminal charged side chains of TTQF-SO3 enable a solubility in aqueous media greater than 100 mg mL−1, such that TTQF-SO3 dissolves into water directly without the assistance of any organic solvents (like dimethyl sulfoxide or alcohols) or encapsulation poly(ethylene glycol) coatings). Dynamic light scattering and transmission electron microscopy results revealed that TTQF-SO3 can self-assemble to form ultra-small dots with 8.7 nm average size (Fig. 1b). Zeta potential measurement revealed a negative surface charge (− 14.3 mV) for TTQF-SO3 in PBS (Additional file 1: Fig. S3a). Furthermore, TTQF-SO3 kept a good colloidal stability either in phosphate-buffered saline (PBS) and dulbecco’s modified eagle medium (DMEM) within 14 days (Additional file 1: Fig. S3b). Some other key properties of TTQF-SO3 in water media is shown in Fig. 1c. The absorption and fluorescence emission spectra of TTQF-SO3 were measured. The characteristic absorption and emission peaks were observed at around 742 nm and 1064 nm, respectively, with a significant stokes shift of 322 nm (Fig. 1d). The molar extinction coefficient of TTQF-SO3 at 808 nm was determined to be 11,254 M−1 cm−1 (Additional file 1: Fig. S4). The NIR-II signals of TTQF-SO3 were compared using various long-pass (LP) filters (1000–1400 nm) at the same concentration in water media, and found that the fluorescence signals can be clearly observed with each filter, even with the 1300–1400 nm LP filter (Fig. 1e). The quantum yield (QY) of TTQF-SO3 was determined to be 0.11%, using IR26 as a reference (QY = 0.05% in DCE, Fig. 1f and Additional file 1: Fig. S5). Moreover, the photostability of the TTQF-SO3 was much superior to that of IR1061, under continuous laser irradiation (Additional file 1: Fig. S6). All these results can be sufficient to support TTQF-SO3 for NIR-II medical imaging possibilities.

Fig. 1
figure 1

a Chemical structure of TTQF-SO3. b DLS and TEM image of TTQF-SO3 in water. c Physicochemical properties of TTQF-SO3. d Normalized absorption and emission spectrum of TTQF-SO3 in water. e NIR-II signals of TTQF-SO3 obtained with different filters at the same concentration (0.1 mg mL−1) in water. f The integrated fluorescence spectra of TTQF-SO3 and its versus different absorbance at 808 nm (IR-26 as reference, QY = 0.05% in dichloroethane)

The affinity binding ability to bone tissue minerals is usually an important criterion for evaluating bone-targeted imaging. To verify whether in vitro binding affinity of TTQF-SO3 toward inorganic calcium salt, different calcium-binding tests were investigated, including calcium pyrophosphate (CPP), calcium oxalate (CO), hydroxyapatite (HA), and calcium carbonate (CC). As shown in Fig. 2a, TTQF-SO3 demonstrated strong affinity for HA compared to other calcium salts, and its fluorescence intensity was about 3-folds than that of other calcium salts (Fig. 2b), which can be attributed to the hydroxyl group of HA contributes to form a strong hydrogen bond with the sulfonyl anion of the fluorophore. [21, 25] Since HA is a major component of bone, we expected that TTQF-SO3 would have a good bone-targeted ability in vivo.

Fig. 2
figure 2

a Calcium-binding NIR-II fluorescence image (NIR-II FI) of TTQF-SO3. Imaging parameters: 1300 filter, exposure 500 ms. b Corresponding quantitative NIR-II fluorescent signals of TTQF-SO3. c NIR-II FI of different cells (3T3, 143B, and J774A.1) treated with TTQF NPs and TTQF-SO3 at different time points. Imaging parameters: 1300 filter, exposure 3000 ms. d Corresponding quantitative NIR-II fluorescent signals of TTQF NPs and TTQF-SO3 bound cells. e NIR-II FI of TTQF-SO3 in mice after intravenous injection. Imaging parameters: 1300 filter, exposure 3000 ms. f NIR-II FI of lymphatic vessels after footpad injection of TTQF-SO3 at 60 min. g Cross-sectional signal profile of lymphatic vessels in the selected region. Error bars, mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001

Motivated by the above promising results, we conducted further tests at the cellular level. As is well known, the interaction between nanomaterials and cells mainly includes electrostatic interaction, water transport interaction, hydrogen bond interaction, π–π stacking and steric hindrance [26]. Among them, the surface charge properties of nanoparticles not only have a great effect on blood circulation, but also on cell uptake [27]. Therefore, three cell lines associated with bone metabolism, including embryonic fibroblast selection (3T3), osteosarcoma (143B), and mouse mononuclear macrophages (J774A.1), were selected for cell uptake studies [28]. The non-functionalized precursor TTQF nanoparticles (NPs) was prepared as a control group by co-deposition with the amphiphilic Pluronic F-127. Detailed characteristics of TTQF NPs were listed in Additional file 1: Fig. S7. The three kinds of cells were incubated with TTQF-SO3 and TTQF NPs, respectively for 30, 60, and 120 min, and their fluorescence signals were monitored by NIR-II imager. As shown in Fig. 2c, there was a significant difference in the fluorescence intensity of the two probes with macrophages at 120 min (P < 0.001). In contrast, the uptake of the two probes in 3T3 and 143B cells was nearly no difference. More accurately, these two probes are not easy to be absorbed by 3T3 and 143B cells in a short time. Considering that the QY (0.24%) of TTQF NPs is 2.2-fold than that of TTQF-SO3 (0.11%), TTQF-SO3 exhibited 14.7-fold higher uptake in J774A.1 cells than that of TTQF NPs at 120 min (Fig. 2d, Additional file 1: Fig. S5). This result indicated that TTQF-SO3 was easily absorbed by undifferentiated monocytes, which may be closely related to its surface charge.

Given the excellent macrophage uptake behavior of TTQF-SO3 in vitro, we further studied its biological distribution in vivo. As illustrated in Additional file 1: Fig. S8a, with 30 min after the injection of TTQF-SO3 (1.0 mg mL−1, 100 μL) through the tail vein, the vascular signal decreased significantly, while the liver signal increased remarkably, indicating that the probe was rapidly captured by the endothelial reticular system [29]. It is worth noting that the mouse tail lymph can be clearly observed at the time point of 2 h, indicating that TTQF-SO3 can enter the lymphatic system through blood circulation (Fig. 2e). This result can be attributed to its reasonable negative charge density, which enables it to pass through the interstitial matrix filled with collagen fibers and negatively charged glycosaminoglycans [30]. Furthermore, the lymph nodes and lymph vessel (LV) can be clearly observed after footpad injection of TTQF-SO3 at 60 min (Fig. 2f; Additional file 1: Fig. S8b). The result of cross-sectional signal profile of LVs displayed the LVs-to-muscle ratios of 8.9 with remarkably sharp features (the full width at half-maximums (FWHMs) of LVs was 130 μm). Overall, TTQF-SO3 could provide alternative modalities for imaging the lymphatic system intraoperatively.

Before evaluation of bone-targeted imaging, the cytotoxicity of TTQF-SO3 was investigated. As demonstrated in Additional file 1: Fig. S9a, 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays showed that TTQF-SO3 showed very low cytotoxicity, and the survival rate of cells could reach more than 90% even at high concentration (0.2 mg mL−1). Hemolysis also showed that TTQF-SO3 had very low biotoxicity, even at 4 mg mL−1 concentration (Additional file 1: Fig. S9b). Next, TTQF-SO3 was intravenously injected (1.0 mg mL−1, 100 μL) into the tail of normal mice to measured its biodistribution using the 1300 nm LP filter. In addition, the non-functionalized precursor TTQF NPs was prepared as a control group by co-deposition with the amphiphilic Pluronic F-127. From NIR-II FI results (Fig. 3a, b; Additional file 1: Figs. S10 and S12), the TTQF-SO3 provided a high-sensitivity and signal-to-background ratios (SBRs) in the normal bones compared with TTQF NPs (Additional file 1: Figs. S11 and S13), revealing that the bones were easier to be recognized by a sulfonated fluorophore (TTQF-SO3) rather than an unsulfonated fluorophore (TTQF). The SBR of the spine was reached a peak of 2.7 at 8 h after injection with TTQF-SO3 (Fig. 3c). By contrast, the SBR was only reached a peak of 1.2 at 8 h after injection with TTQF NPs, which was far below than that of TTQF-SO3 at almost all time points (Fig. 3c). Furthermore, the above NIR-II FI results were quantitatively analyzed. As observed in Fig. 3d, parallel analysis (red line) along the spine showed three peaks of fluorescence intensity in the mouse injected with TTQF-SO3, high enough to distinguish different vertebrae. The FWHMs were ranging from 1.49 to 1.94 mm. Vertical analysis crossing the spine (yellow line) also exhibited a good differentiation (FWHM = 0.58 mm) between the vertebrae and others (Fig. 3e).

Fig. 3
figure 3

a, b NIR-II FI of BALB/c mice at 12 h post-injection using TTQF-SO3. White dotted box: soft tissue. Imaging parameters: 1300 filter, exposure 3000 ms. c Spine-soft tissue fluorescence ratio of TTQF-SO3 and TTQF NPs at different time-point. d FL intensity analysis of the red line in a. e FL intensity analysis of the yellow line in a. f NIR-II FI of the whole skeletal system using TTQF-SO3. gn Stereomicroscope NIR-II FI of some pivotal skeletal system using TTQF-SO3. Imaging parameters: 1300 filter, exposure 500 ms. Error bars, mean ± SD (n = 3)

Then, the ex vivo NIR-II FI was performed on isolated bone tissues of the healthy mouse after injected with TTQF-SO3. As displayed in Fig. 3f, the entire skeletal system can be clearly imaged from the prone position after removing soft tissues. Moreover, the details of bone images at various sites were also performed using a NIR-II stereomicroscope (Fig. 3g–n). Figure 3g clearly displays the thoracic vertebrae and dorsal rib of the normal mouse. Figure 3h clearly exhibits the lumbar. It’s worth noting that the spinous and transverse processes can be observed in the images. Similarly, the caudal vertebrae can also be observed in Fig. 3i. In addition, Fig. 3j shows the ilium and ischium, and Fig. 3k displays the skull of the mouse. Likewise, the following images exhibits the sternum and sternal rib (Fig. 3l), digital and metatarsal bone (Fig. 3m), tibia, patella, and femur (Fig. 3n) in turn. It should be noted that the soft ribs of the chest were not shown in Fig. 3l, which means that TTQF-SO3 could not be enriched in the cartilage tissue on account of different composition of cartilage and bone tissue [31]. All the data suggested that the small-molecule TTQF-SO3 has specifically bone-binding affinity to successfully visualize the whole skeletal system in vivo, which has the potential for real-time intraoperative bone imaging.

In view of the outstanding bone imaging quality of TTQF-SO3 in normal mice, osteoporosis model mice were selected for further evaluated its NIR-II bone-imaging. TTQF-SO3 (100 μL, 1.0 mg mL−1) was injected into normal mice (n = 3) and osteoporosis mice (n = 3) through the tail vein, and then NIR-II FI were taken at different time points (Additional file 1: Fig. S14). As exhibited in Fig. 4a, after 30 min injection, TTQF-SO3-based NIR-II FI exhibited significant differences between the legs of osteoporosis mice and normal mice. Within 2 h after injection, the SBR value in the legs of osteoporosis mice was higher than that of normal mice from beginning to end, and the quality of NIR-II FI was significantly improved (Fig. 4b). The higher accumulation of TTQF-SO3 in osteoporosis mice may be attributed to osteoclast activity. These osteoclast precursors belong to the monocyte/macrophage class and have similar phagocytosis capabilities, therefore, TTQF-SO3 can be easily accumulated into bone, which is consistent with cellular uptake data.

Fig. 4
figure 4

a NIR-II FI of normal mice and osteoporosis mice in supine position were obtained at 0.5 and 2 h after injection, respectively. Imaging parameters: 1300 filter, exposure 3000 ms. Dotted box in white: soft tissue. b Corresponding leg-tissue fluorescence signal ratio of the two groups. c NIR-II FI of skulls in normal (left) and osteoporotic mice (right). Imaging parameters: 1300 filter, exposure 500 ms. d NIR-II FI of shanks in normal (left) and osteoporotic mice (right). e, f Corresponding normalized FL intensity distribution along yellow/red lines in corresponding figures c and d. Error bars, mean ± SD (n = 3)

After removing the skin and viscera from osteoporotic mice, we further performed in vitro NIR-II FI analysis using an NIR-II microscope (Additional file 1: Fig. S15). Compared with normal mice, the osteoporotic mice had defects on the surface of their bones, particularly the skull and kneecaps (Fig. 4c, d). Further quantitative bone analysis in vitro showed that the fluorescence intensity curves of the skull and kneecap of normal mice showed a large broad peak, while those of osteoporosis mice exhibited many distinct sharp peaks (Fig. 4e, f). These results suggested that the bone surface of the osteoporosis mice was uneven. In addition, quantitative fluorescence signals of skulls and shanks ex vivo were further evaluated (Additional file 1: Fig. S16). The fluorescence intensity of TTQF-SO3 in skull and shank of osteoporotic mice increased by approximately 3.0- and 1.3-fold, respectively, higher than that of normal mice, indicating the superior accumulation ability for osteoporotic mice.

The in vivo biosafety of TTQF-SO3 was further evaluated. As shown in Figure S17 (Supporting Information), the main organs in vitro showed that TTQF-SO3 was mainly accumulated in liver and spleen. Moreover, no obvious inflammation or abnormalities were observed in major organs of mice after injection of TTQF-SO3, demonstrating that the fluorescent probe has good biocompatibility (Fig. 5; Additional file 1: Fig. S18). Furthermore, the normal mouse injected with TTQF-SO3 can still observe the fluorescence signals of the liver and bone after 21 days, indicating that the fluorophore can remain in vivo for a long time (Additional file 1: Fig. S19). Predictably, long-term retention feature of TTQF-SO3 in bone tissue may serve as targeting group to deliver drugs to primary bone tumors, bone metastases, osteoporosis, osteomyelitis and so on.

Fig. 5
figure 5

Blood routine tests of mice were performed after the treatment with TTQF-SO3 (100 μL, 1.0 mg mL−1) during 30 days. Error bars, mean ± SD (n = 3)

Conclusion

In conclusion, an efficient bone targeting probe based on NIR-II fluorophore was successfully developed by grafting a specific number of sulfonate group. TTQF-SO3 shows excellent calcium-binding, bone-targeted features and outstanding biosecurity, which can be used for non-invasive and non-radiation bone tissues visualization and further monitoring of bone related diseases in vivo, such as osteoporosis. In vitro and in vivo results further support that our TTQF-SO3 has high imaging resolution and outstanding biocompatibility, which expected to be further applied in preclinical research of bone imaging. This study may become in vivo bone targeting design strategy besides the classical phosphate modification.

Data Availability

All data needed to support the conclusions are present in the paper and/or the Supporting Information. Additional data related to this study are available from the corresponding authors upon reasonable.

References

  1. Marks SC, Popoff SN. Bone cell biology: the regulation of development, structure, and function in the skeleton. Am J Anat. 1988;183:1–44.

    Article  PubMed  Google Scholar 

  2. Yun B, Maburutse BE, Kang M, Park MR, Park DJ, Kim Y, Oh S. Short communication: dietary bovine milk-derived exosomes improve bone health in an osteoporosis-induced mouse model. J Dairy Sci. 2020;103:7752–60.

    Article  CAS  PubMed  Google Scholar 

  3. Yan R, Guo Y, Wang X, Liang G, Yang A, Li J. Near-infrared light-controlled and real-time detection of osteogenic differentiation in mesenchymal stem cells by upconversion nanoparticles for osteoporosis therapy. ACS Nano. 2022;16:8399–418.

    Article  CAS  PubMed  Google Scholar 

  4. Zhou X, Cornel EJ, Fan Z, He S, Du J. Bone-targeting polymer vesicles for effective therapy of osteoporosis. Nano Lett. 2021;21:7998–8007.

    Article  CAS  PubMed  Google Scholar 

  5. Bao K, Nasr KA, Hyun H, Lee JH, Gravier J, Gibbs SL, Choi HS. Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging. Theranostics. 2015;5:609–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ogawa K, Washiyama K. Bone target radiotracers for palliative therapy of bone metastases. Curr Med Chem. 2012;19:3290–300.

    Article  CAS  PubMed  Google Scholar 

  7. Rasulova N, Lyubshin V, Arybzhanov D, Sagdullaev S, Krylov V, Khodjibekov M. Optimal timing of bisphosphonate administration in combination with samarium-153 oxabifore in the treatment of painful metastatic bone disease. World J Nucl Med. 2013;12:14–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Li C, Chen G, Zhang Y, Wu F, Wang Q. Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications. J Am Chem Soc. 2020;142:14789–804.

    Article  CAS  PubMed  Google Scholar 

  9. Cen P, Zhou Y, Cui C, Wei Y, Cheng Z, Wu S, Zhang H, Tian M. Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens. Eur J Nucl Med Mol. 2022;I(49):4529–50.

    Article  Google Scholar 

  10. Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol. 2001;19:1148–54.

    Article  CAS  PubMed  Google Scholar 

  11. Li Y, Lu S, Zhang Y, Li J, Zhang J, Zhang C, Xiong L. Multifunctional imaging of vessels, brown adipose tissue, and bones in the visible and second near-infrared region using dual-emitting polymer dots. ACS Appl Mater Interfaces. 2022;14:37504–13.

    Article  CAS  PubMed  Google Scholar 

  12. Wan H, Du HT, Wang FF, Dai HJ. Molecular imaging in the second near-infrared window. Adv Funct Mater. 2019;29:1900566.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Antaris AL, Chen H, Cheng K, Sun Y, Hong G, Qu C, Diao S, Deng Z, Hu X, Zhang B, Zhang X, Yaghi OK, Alamparambil ZR, Hong X, Cheng Z, Dai H. A small-molecule dye for NIR-II imaging. Nat Mater. 2016;15:235–42.

    Article  CAS  PubMed  Google Scholar 

  14. Chen Y, Chen S, Yu H, Wang Y, Cui M, Wang P, Sun P, Ji M. D-A type NIR-II organic molecules: strategies for the enhancement fluorescence brightness and applications in NIR-II fluorescence imaging-navigated photothermal therapy. Adv Health Mater. 2022;11:2201158.

    Article  CAS  Google Scholar 

  15. Zhou Q, Nozdriukhin D, Chen Z, Glandorf L, Hofmann UAT, Reiss M, Tang L, Deán-Ben XL, Razansky D. Depth-resolved localization microangiography in the NIR-II window. Adv Sci. 2023;10:2204782.

    Article  CAS  Google Scholar 

  16. Kubicek V, Lukes I. Bone-seeking probes for optical and magnetic resonance imaging. Future Med Chem. 2010;2:521–31.

    Article  CAS  PubMed  Google Scholar 

  17. Harmatys KM, Cole EL, Smith BD. In vivo imaging of bone using a deep-red fluorescent molecular probe bearing multiple iminodiacetate groups. Mol Pharmaceutics. 2013;10:4263–71.

    Article  CAS  Google Scholar 

  18. Li X, Pan C, Cao J, Liu Z, Zhu Z, Yan C, Zhao W, Zhu WH, Wang Q. An AIE-active probe for monitoring calcium-rich biological environment with high signal-to-noise and long-term retention in situ. Biomaterials. 2022;289: 121778.

    Article  CAS  PubMed  Google Scholar 

  19. Wang H, Kang H, Dinh J, Yokomizo S, Stiles WR, Tully M, Cardenas K, Srinivas S, Ingerick J, Ahn S, Bao K, Choi HS. P800SO3-PEG: a renal clearable bone-targeted fluorophore for theranostic imaging. Biomater Res. 2022;26:51–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Li YG, Kim HJ, Kim JW, Park K. Calcium-binding near-infrared fluorescent nanoprobe for bone tissue imaging. J Ind Eng Chem. 2020;89:442–7.

    Article  Google Scholar 

  21. Hyun H, Wada H, Bao K, Gravier J, Yadav Y, Laramie M, Henary M, Frangioni JV, Choi HS. Phosphonated near-infrared fluorophores for biomedical imaging of bone. Angew Chem Int Ed. 2014;53:10668–72.

    Article  CAS  Google Scholar 

  22. Sun S, Błazewska KM, Kadina AP, Kashemirov BA, Duan X, Triffitt JT, Dunford JE, Russell RGG, Ebetino FH, Roelofs AJ, Coxon FP, Lundy MW, McKenna CE. Fluorescent bisphosphonate and carboxyphosphonate probes: a versatile imaging toolkit for applications in bone biology and biomedicine. Bioconjugate Chem. 2016;27:329–40.

    Article  CAS  Google Scholar 

  23. Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011;48:677–92.

    Article  CAS  PubMed  Google Scholar 

  24. Zhang X, Ji A, Wang Z, Lou H, Li J, Zheng L, Zhou Y, Qu C, Liu X, Chen H, Cheng Z. Azide-dye unexpected bone targeting for near-infrared window II osteoporosis imaging. J Med Chem. 2021;64:11543–53.

    Article  CAS  PubMed  Google Scholar 

  25. Moriguchi T, Yano K, Nakagawa S, Kaji F. Elucidation of adsorption mechanism of bone-staining agent alizarin red S on hydroxyapatite by FT-IR microspectroscopy. J Colloid Interf Sci. 2003;260:19–25.

    Article  CAS  Google Scholar 

  26. Debnath K, Pal S, Jana NR. Chemically designed nanoscale materials for controlling cellular processes. Acc Chem Res. 2021;54:2916–27.

    Article  CAS  PubMed  Google Scholar 

  27. Murthy AK, Stover RJ, Hardin WG, Schramm R, Nie GD, Gourisankar S, Truskett TM, Sokolov KV, Johnston KP. Charged gold nanoparticles with essentially zero serum protein adsorption in undiluted fetal bovine serum. J Am Chem Soc. 2013;135:7799–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ge P, Cui Y, Liu F, Luan J, Zhou X, Han J. l-carnitine affects osteoblast differentiation in NIH3T3 fibroblasts by the IGF-1/PI3K/Akt signalling pathway. BioSci Trends. 2015;9:42–8.

    Article  CAS  PubMed  Google Scholar 

  29. Li J, Liu J, Chen C. Remote control and modulation of cellular events by plasmonic gold nanoparticles: implications and opportunities for biomedical applications. ACS Nano. 2017;11:2403–9.

    Article  CAS  PubMed  Google Scholar 

  30. Pang Z, Yan W, Yang J, Li Q, Guo Y, Zhou D, Jiang X. Multifunctional gold nanoclusters for effective targeting, near-infrared fluorescence imaging, diagnosis, and treatment of cancer lymphatic metastasis. ACS Nano. 2022;16:16019–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hsu KF, Su SP, Lu HF, Liu MH, Chang YJ, Lee YJ, Chiang HK, Hsu CP, Lu CW, Chan YH. TADF-based NIR-II semiconducting polymer dots for in vivo 3D bone imaging. Chem Sci. 2022;13:10074–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful for financially support from the National Natural Science Foundation of China (82102588, Daifeng Li), Natural Science Fundation for Excellent Young Scholars of Henan Province (232300421050, Daifeng Li), Young and Middle-Aged Discipline Leader of Henan Provincial Health Commission (HNSWJW2022007, Daifeng Li), Youth Talent Promotion Project of Henan Province (2023HYTP042, Daifeng Li), Key Projects of Medical Science and Technology of Henan Province (SBGJ202102116, Daifeng Li and SBGJ202102125, Chi Zhang), Natural Science Foundation of Jiangsu Province (BK20201380, Pengfei Sun), Scientific Research Foundation for Returned Scholars of Henan Province (Daifeng Li) and Youth Talent Innovation Team Support Program of Zhengzhou University (32320359, Daifeng Li). The authors acknowledge assistance with the access to analytic instruments from the Translational Medicine Center at the First Affiliated Hospital of Zhengzhou University.

Author information

Authors and Affiliations

Authors

Contributions

DL, CZ and PS conceived the project and designed the experiments. FQ synthesized the chemicals. PC and FQ performed the spectral and cell experiments and analyzed the data. LH and ML performed the animal experiments. DL, CZ and PS supervised the project. QF helped with the revision of this manuscript. All of the authors were involved in the analysis and interpretation of data.

Corresponding authors

Correspondence to Pengfei Sun, Chi Zhang or Daifeng Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: Experimental section and supporting figures associated with this article can be found in the online version.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, P., Qu, F., He, L. et al. Quasi-dendritic sulfonate-based organic small molecule for high-quality NIR-II bone-targeted imaging. J Nanobiotechnol 21, 230 (2023). https://doi.org/10.1186/s12951-023-01999-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12951-023-01999-9

Keywords